Active, not recruitingPhase 1NCT04877613

GFRα4 CAR T Cells in MTC Patients

Studying Medullary thyroid carcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Pennsylvania
Principal Investigator
Roger Cohen, MD
University of Pennsylvania
Intervention
single dose of CART-GFRa4 cells(drug)
Enrollment
18 enrolled
Eligibility
18 years · All sexes
Timeline
2021 – 2039

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04877613 on ClinicalTrials.gov

Other trials for Medullary thyroid carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Medullary thyroid carcinoma →

← Back to all trials